^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
New
Source:
Title:

Antimyeloma activity of bromodomain inhibitors on the human myeloma cell line U266 by downregulation of MYCL

Excerpt:
...Karpas 620 CCND1 line was selected for its high Bcl-xL expression. Puma and Bim were found associated with both Bcl-2 and Bcl-xL in this cell line. After 6 h of ABT-199 treatment (25 nm), Puma/Bcl-2 and Bim/Bcl-2 complexes were disrupted in contrast to the Bcl-xL heterodimers that were not modified (Figure 1c)....Sensitivity to ABT-199 was significantly associated with higher expression of Bcl-2 (P=0.008) and tended to be associated with a lower Mcl-1 expression (P=0.09) (Supplementary Figure 2).
DOI:
https://dx.doi.org/10.1038%2Fleu.2013.216